ANTISENSE TECHNOLOGY

Welcome to the Brand page for “ANTISENSE TECHNOLOGY”, which is offered here for Ophthalmic pharmaceutical preparation for the treatment of cytomegalovirus retinitis;antisense technology;the stippling in the drawing is for shading purposes only.;.

Its status is currently believed to be active. Its class is unavailable. “ANTISENSE TECHNOLOGY” is believed to be currently owned by “NOVARTIS AG”.


Owner:
NOVARTIS AG
Owner Details
Description:
OPHTHALMIC PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS;ANTISENSE TECHNOLOGY;The stippling in the drawing is for shading purposes only.;
Categories: OPHTHALMIC PHARMACEUTICAL PREPARATION